Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies
Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies
Analyzing survival in HIV treatment cohorts, Andrew Boulle and colleagues find mortality rates in South Africa comparable to or better than those in North America by 4 years after starting antiretroviral therapy. Please see later in the article for the Editors' Summary
Reference:
Boulle, A., Schomaker, M., May, M. T., Hogg, R. S., Shepherd, B. E., Monge, S., ... & Sterne, J. A. (2014). Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies. PLoS medicine, 11(9), e1001718. doi:10.1371/journal.pmed.1001718
Boulle, A., Schomaker, M., May, M. T., Hogg, R. S., Shepherd, B. E., Monge, S., ... Ndirangu, J. (2014). Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies. PLOS Medicince, http://hdl.handle.net/11427/14992
Boulle, Andrew, Michael Schomaker, Margaret T May, Robert S Hogg, Bryan E Shepherd, Susana Monge, Olivia Keiser, Fiona C Lampe, Janet Giddy, and James Ndirangu "Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies." PLOS Medicince (2014) http://hdl.handle.net/11427/14992
Boulle A, Schomaker M, May MT, Hogg RS, Shepherd BE, Monge S, et al. Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies. PLOS Medicince. 2014; http://hdl.handle.net/11427/14992.
Except where otherwise noted, this item's license is described as This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Except where otherwise noted, this item's license is described as This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.